NeuroPace Future Growth
Future criteria checks 2/6
NeuroPace is forecast to grow earnings and revenue by 27.2% and 21.2% per annum respectively. EPS is expected to grow by 31.6% per annum. Return on equity is forecast to be -315% in 3 years.
Key information
27.2%
Earnings growth rate
31.6%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 21.2% |
| Future return on equity | -315.0% |
| Analyst coverage | Good |
| Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Here's What Analysts Are Forecasting For NeuroPace, Inc. (NASDAQ:NPCE) After Its Third-Quarter Results
Nov 14
Does NeuroPace (NASDAQ:NPCE) Have A Healthy Balance Sheet?
Nov 07NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch
Aug 03Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12NeuroPace: Picking Up The Pace
Feb 25Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge
Jan 22NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company
Apr 17NeuroPace announces U.S. distribution agreement with DIXI Medical
Aug 11NeuroPace EPS misses by $32.45, beats on revenue; issues guidance
Jun 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 109 | -18 | -8 | -6 | 6 |
| 12/31/2025 | 91 | -27 | -16 | -15 | 7 |
| 12/31/2024 | 79 | -29 | -20 | -20 | 7 |
| 9/30/2024 | 76 | -28 | -17 | -16 | N/A |
| 6/30/2024 | 72 | -30 | -17 | -17 | N/A |
| 3/31/2024 | 69 | -32 | -18 | -18 | N/A |
| 12/31/2023 | 65 | -33 | -20 | -20 | N/A |
| 9/30/2023 | 60 | -38 | -24 | -24 | N/A |
| 6/30/2023 | 55 | -42 | -29 | -29 | N/A |
| 3/31/2023 | 49 | -46 | -36 | -35 | N/A |
| 12/31/2022 | 46 | -47 | -37 | -37 | N/A |
| 9/30/2022 | 44 | -47 | -38 | -37 | N/A |
| 6/30/2022 | 43 | -43 | -35 | -35 | N/A |
| 3/31/2022 | 45 | -39 | -31 | -30 | N/A |
| 12/31/2021 | 45 | -36 | -25 | -25 | N/A |
| 9/30/2021 | 45 | -30 | -23 | -23 | N/A |
| 6/30/2021 | 47 | -26 | -24 | -24 | N/A |
| 3/31/2021 | 42 | -26 | -21 | -21 | N/A |
| 12/31/2020 | 41 | -24 | -22 | -22 | N/A |
| 12/31/2019 | 37 | -30 | -25 | -25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NPCE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NPCE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NPCE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NPCE's revenue (21.2% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: NPCE's revenue (21.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NPCE is forecast to be unprofitable in 3 years.